Page
%P
-
Article
Open AccessCirculating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin
Recombinant human soluble thrombomodulin (rTM) has been used for the treatment of disseminated intravascular coagulation in Japan, and an international phase III clinical trial for rTM is currently in progress...